Gene Page: LCAT
Summary ?
GeneID | 3931 |
Symbol | LCAT |
Synonyms | - |
Description | lecithin-cholesterol acyltransferase |
Reference | MIM:606967|HGNC:HGNC:6522|Ensembl:ENSG00000213398|HPRD:06098|Vega:OTTHUMG00000137551 |
Gene type | protein-coding |
Map location | 16q22.1 |
Pascal p-value | 1.199E-4 |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
snp_a-1919794 | 0 | LCAT | 3931 | 0.08 | trans | |||
rs6546475 | chr2 | 69275427 | LCAT | 3931 | 0.1 | trans | ||
rs12104712 | chr2 | 82644947 | LCAT | 3931 | 1.684E-4 | trans | ||
rs7584986 | chr2 | 184111432 | LCAT | 3931 | 0.01 | trans | ||
rs1285074 | chr3 | 172096819 | LCAT | 3931 | 0.07 | trans | ||
rs1523326 | chr3 | 172106276 | LCAT | 3931 | 0.07 | trans | ||
snp_a-1976228 | 0 | LCAT | 3931 | 0.08 | trans | |||
rs10491487 | chr5 | 80323367 | LCAT | 3931 | 9.258E-4 | trans | ||
rs1368303 | chr5 | 147672388 | LCAT | 3931 | 7.74E-6 | trans | ||
rs4897051 | chr6 | 149118925 | LCAT | 3931 | 0.13 | trans | ||
rs9364293 | chr6 | 169199078 | LCAT | 3931 | 0.02 | trans | ||
rs9654996 | chr7 | 30271955 | LCAT | 3931 | 0.07 | trans | ||
rs4872540 | chr8 | 22598980 | LCAT | 3931 | 0.02 | trans | ||
rs6989594 | chr8 | 126303866 | LCAT | 3931 | 0.02 | trans | ||
rs13293929 | chr9 | 107247254 | LCAT | 3931 | 0.16 | trans | ||
rs10985440 | chr9 | 124664643 | LCAT | 3931 | 0.18 | trans | ||
rs12359579 | chr10 | 87511020 | LCAT | 3931 | 0.13 | trans | ||
rs17104720 | chr14 | 77127308 | LCAT | 3931 | 0.02 | trans | ||
rs16955618 | chr15 | 29937543 | LCAT | 3931 | 0 | trans | ||
snp_a-1830894 | 0 | LCAT | 3931 | 5.709E-6 | trans | |||
rs3786474 | chr18 | 55135672 | LCAT | 3931 | 0.13 | trans | ||
rs3786464 | chr18 | 55138931 | LCAT | 3931 | 0.03 | trans | ||
rs17070739 | chr18 | 60819382 | LCAT | 3931 | 0.02 | trans | ||
rs17085767 | chr18 | 69839397 | LCAT | 3931 | 2.706E-6 | trans | ||
rs16966891 | chr19 | 32809523 | LCAT | 3931 | 0.18 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
RILP | 0.79 | 0.84 |
HSPB2 | 0.78 | 0.83 |
ACOT13 | 0.76 | 0.80 |
GCAT | 0.75 | 0.79 |
DCXR | 0.75 | 0.78 |
BLVRB | 0.73 | 0.77 |
ABHD11 | 0.73 | 0.65 |
ANKRD9 | 0.73 | 0.76 |
TMEM141 | 0.72 | 0.84 |
C19orf46 | 0.72 | 0.61 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
MLL5 | -0.59 | -0.69 |
SUV420H1 | -0.59 | -0.72 |
ZNF711 | -0.59 | -0.69 |
SETD2 | -0.58 | -0.71 |
GRIP1 | -0.58 | -0.69 |
NOL4 | -0.58 | -0.67 |
THOC2 | -0.58 | -0.73 |
PHF3 | -0.58 | -0.71 |
ZBTB8A | -0.58 | -0.67 |
VAV2 | -0.58 | -0.70 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG GLYCEROPHOSPHOLIPID METABOLISM | 77 | 35 | All SZGR 2.0 genes in this pathway |
REACTOME HDL MEDIATED LIPID TRANSPORT | 15 | 12 | All SZGR 2.0 genes in this pathway |
REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS | 478 | 302 | All SZGR 2.0 genes in this pathway |
REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | 46 | 37 | All SZGR 2.0 genes in this pathway |
REACTOME LIPOPROTEIN METABOLISM | 28 | 24 | All SZGR 2.0 genes in this pathway |
LIU PROSTATE CANCER DN | 481 | 290 | All SZGR 2.0 genes in this pathway |
BORCZUK MALIGNANT MESOTHELIOMA DN | 104 | 59 | All SZGR 2.0 genes in this pathway |
LINDGREN BLADDER CANCER CLUSTER 3 DN | 229 | 142 | All SZGR 2.0 genes in this pathway |
TANG SENESCENCE TP53 TARGETS UP | 33 | 20 | All SZGR 2.0 genes in this pathway |
HU ANGIOGENESIS UP | 21 | 16 | All SZGR 2.0 genes in this pathway |
SHIPP DLBCL CURED VS FATAL DN | 45 | 30 | All SZGR 2.0 genes in this pathway |
KANNAN TP53 TARGETS UP | 58 | 40 | All SZGR 2.0 genes in this pathway |
HSIAO LIVER SPECIFIC GENES | 244 | 154 | All SZGR 2.0 genes in this pathway |
WEIGEL OXIDATIVE STRESS RESPONSE | 35 | 28 | All SZGR 2.0 genes in this pathway |
WANG CISPLATIN RESPONSE AND XPC DN | 228 | 146 | All SZGR 2.0 genes in this pathway |
LEE AGING NEOCORTEX UP | 89 | 59 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS STEM CELL AND PROGENITOR | 681 | 420 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER | 49 | 29 | All SZGR 2.0 genes in this pathway |
ACEVEDO LIVER CANCER DN | 540 | 340 | All SZGR 2.0 genes in this pathway |
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE DN | 274 | 165 | All SZGR 2.0 genes in this pathway |
MOOTHA MITOCHONDRIA | 447 | 277 | All SZGR 2.0 genes in this pathway |
HOSHIDA LIVER CANCER LATE RECURRENCE DN | 69 | 48 | All SZGR 2.0 genes in this pathway |
HOSHIDA LIVER CANCER SUBCLASS S3 | 266 | 180 | All SZGR 2.0 genes in this pathway |
CAIRO HEPATOBLASTOMA DN | 267 | 160 | All SZGR 2.0 genes in this pathway |
CAIRO LIVER DEVELOPMENT DN | 222 | 141 | All SZGR 2.0 genes in this pathway |
CHYLA CBFA2T3 TARGETS DN | 242 | 146 | All SZGR 2.0 genes in this pathway |
LIM MAMMARY STEM CELL UP | 489 | 314 | All SZGR 2.0 genes in this pathway |
ZWANG TRANSIENTLY UP BY 1ST EGF PULSE ONLY | 1839 | 928 | All SZGR 2.0 genes in this pathway |